Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| October 14th, 2019 |
Orphans and Vulnerable Children |
Mozambique USAID Maputo |
| August 4th, 2020 |
Announcement of the Availability of Funds for Research Integrity Program Development and Evaluation |
Office of the Assistant Secretary for Health |
| August 4th, 2020 |
Announcement of the Availability of Funds for Conferences on Research Integrity |
Office of the Assistant Secretary for Health |
| August 4th, 2020 |
Announcement of Availability of Funds for Research to Practice Center Grants for Adolescent Health Promotion in Order to Prevent Teenage Pregnancy |
Office of the Assistant Secretary for Health |
| August 4th, 2020 |
Announcement of the Availability of Funds for Research on Research Integrity |
Office of the Assistant Secretary for Health |
| August 4th, 2020 |
Pregnancy Prevention Research Grants |
Office of the Assistant Secretary for Health |
| August 25th, 2020 |
National Training Center for Family Planning and Teen Pregnancy Prevention |
Office of the Assistant Secretary for Health |
| November 8th, 2022 |
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2022 |
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2021 |
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2022 |
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
National Institutes of Health |
| August 11th, 2021 |
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
National Institutes of Health |
| August 11th, 2021 |
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
National Institutes of Health |
| August 11th, 2021 |
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials |
National Institutes of Health |
| March 10th, 2020 |
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events |
Centers for Disease Control and Prevention ERA |
| February 18th, 2020 |
Modeling Infectious Diseases in Healthcare Research Projects to Improve Prevention Research and Healthcare Delivery (MInD Healthcare) |
Centers for Disease Control and Prevention ERA |
| April 14th, 2020 |
Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence |
Centers for Disease Control and Prevention ERA |
| February 25th, 2020 |
Rapid-Cycle Survey Collaborative for Patient and Provider Input on Immunization Issues |
Centers for Disease Control and Prevention ERA |
| May 17th, 2022 |
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) |
National Institutes of Health |
| November 8th, 2019 |
State and Regional Primary Care Association (PCA) Cooperative Agreements |
Health Resources and Services Administration |
|
| January 14th, 2022 |
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2021 |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
National Institutes of Health |
| August 11th, 2021 |
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| August 11th, 2021 |
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2022 |
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
| April 27th, 2020 |
Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally |
Centers for Disease Control CGH |
| October 1st, 2021 |
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| November 1st, 2019 |
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 23rd, 2021 |
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) |
National Institutes of Health |
| June 23rd, 2021 |
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) |
National Institutes of Health |
| June 23rd, 2021 |
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) |
National Institutes of Health |
| June 23rd, 2021 |
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) |
National Institutes of Health |
| June 23rd, 2021 |
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
| December 3rd, 2019 |
Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 7th, 2019 |
Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Scientific and Data Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
| November 7th, 2019 |
Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers (U01 Clinical Trial Optional) |
National Institutes of Health |
| November 15th, 2019 |
Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed) |
National Institutes of Health |
| May 7th, 2021 |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 14th, 2020 |
Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) |
Centers for Disease Control and Prevention ERA |
| February 4th, 2020 |
Natural Experiments of the Impact of Population-targeted Policies to Prevent Type 2 Diabetes and Diabetes Complications |
Centers for Disease Control and Prevention ERA |
